T-Cell Lymphoblastic Leukemia/Lymphoma
1 clinical trials · Condition
◉ Watch T-Cell Lymphoblastic Leukemia/Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) (NCT05885464) | Beam Therapeutics Inc. | 2023-05-25 |
Track T-Cell Lymphoblastic Leukemia/Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.